98%
921
2 minutes
20
Background: Fetal exposure to tobacco increases the risk for many adverse birth outcomes, but whether diet mitigates these risks has yet to be explored. Here, we examined whether maternal folate intake (from foods and supplements) during pregnancy modified the association between prenatal exposure to tobacco and with preterm delivery, small-for-gestational age (SGA) births, or neonatal adiposity.
Methods: Mother-child pairs (n = 701) from Healthy Start were included in this analysis. Urinary cotinine was measured at ~ 27 weeks gestation. Diet was assessed using repeated 24-h dietary recalls. Neonatal adiposity (fat mass percentage) was measured via air displacement plethysmography. Interaction was assessed by including a product term between cotinine (< / ≥ limit of detection [LOD]) and folate (< / ≥ 25 percentile [1077 µg/day]) in separate logistic or linear regression models, adjusting for maternal age, race, ethnicity, education, pre-pregnancy body mass index, and infant sex.
Results: Approximately 26% of women had detectable levels of cotinine. Folate intake was significantly lower among women with cotinine ≥ LOD as compared to those with cotinine < LOD (1293 µg/day vs. 1418 µg/day; p = 0.01). Folate modified the association between fetal exposure to tobacco with neonatal adiposity (p for interaction = 0.07) and SGA (p for interaction = 0.07). Among those with lower folate intake, fetal exposure to tobacco was associated with lower neonatal adiposity (mean difference: -2.09%; 95% CI: -3.44, -0.74) and increased SGA risk (OR: 4.99; 95% CI: 1.55, 16.14). Conversely, among those with higher folate intake, there was no difference in neonatal adiposity (mean difference: -0.17%; 95% CI: -1.13, 0.79) or SGA risk (OR: 1.15; 95% CI: 0.57, 2.31).
Conclusions: Increased folate intake during pregnancy (from foods and/or supplements) may mitigate the risk of fetal growth restriction among those who are unable to quit smoking or cannot avoid secondhand smoke during pregnancy.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465971 | PMC |
http://dx.doi.org/10.1186/s40748-022-00141-1 | DOI Listing |
Rev Panam Salud Publica
September 2025
Department of Health Promotion, Education and Behavior Arnold School of Public Health University of South Carolina Columbia USA Department of Health Promotion, Education and Behavior, Arnold School of Public Health, University of South Carolina, Columbia, USA.
Objective: This study investigates awareness of and support for Mexico's bans on e-cigarettes and heated tobacco products among adults who smoke.
Methods: Data were analyzed from a 2020 survey of adult Mexicans who exclusively smoked cigarettes ( = 1 324) or smoked cigarettes and used e-cigarettes ( = 654). Weighted multilevel mixed-effects logistic regression models estimated crude and adjusted odds ratios (AORs) for awareness of and support for bans on each product, regressing these outcomes on variables for sociodemographic characteristics, product use, perceptions of harms, norms and exposure to advertising.
Nicotine Tob Res
August 2025
Section of Pulmonary and Critical Care, Department of Medicine, Dartmouth-Hitchcock Medical Center, 1 Medical Center Dr, Lebanon, NH, 03766, USA.
Introduction: This study examined the main and interactive effects of sex, cigarette smoking status, cigarette pack-years, and second-hand smoke exposure on COPD prevalence and incidence.
Methods: COPD prevalence was estimated for US adults aged 40+ years from Wave 1 of the Population Assessment of Tobacco and Health Study (n = 12 296). Incidence analyses included adults from the initial sample without a COPD diagnosis (n = 6611).
Rheumatology (Oxford)
September 2025
Department of Experimental and Clinical Medicine, Division of Rheumatology, University of Florence, Florence, Italy.
Objectives: To describe the prevalence of gastrointestinal (GI) symptoms in systemic sclerosis (SSc) and Very Early Diagnosis of SSc (VEDOSS), identify clinical and serological features associated with GI involvement, and explore a cranio-caudal pattern of symptom distribution, using data from the Italian SPRING-SIR registry.
Methods: This cross-sectional analysis included patients fulfilling 2013 ACR/EULAR SSc or VEDOSS criteria. GI involvement was defined as symptoms in at least one GI tract segment and categorized as upper and lower.
Exp Lung Res
September 2025
China Tobacco Hubei Industrial Co., Ltd, Wuhan, China.
In recent years, with the increasing severity of air pollution and environmental degradation, research on lung-related diseases has become more intensive. Lung organoids, as 3D culture models, can simulate the local microenvironment and physiological functions of lung tissue and are widely used in studies on the development and mechanisms of lung-related diseases. However, the precise application of lung organoids is still in the developmental stage, particularly regarding the screening and validation of stable housekeeping genes in lung organoids, which remains unclear.
View Article and Find Full Text PDFNicotine Tob Res
September 2025
National Institute on Drug Abuse, 6001 Executive Blvd, N. Bethesda, Maryland 20852.
Introduction: Flavors play an important role in e-cigarette use among both young people and adults, but evaluations of flavored e-cigarette policies have focused almost exclusively on youth. This longitudinal study examined how flavored e-cigarette policies affect tobacco use over time for different adult age groups using data from the Population Assessment of Tobacco and Health (PATH) Study.
Methods: Adults age 21+ at Wave 5 (2018-2019) comprised the analytic sample.